Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Impact Of Spironolactone On Longitudinal Changes In Health-Related Quality Of Life In The Treatment Of Preserved Cardiac Function Heart Failure With An Aldosterone Antagonist Trial, Eldrin Lewis, Hae-Young Kim, Brian Claggett, John Spertus, John F Heitner, Susan F Assmann, Christopher T Kenwood, Scott D Solomon, Akshay S Desai, James C Fang, Sonia A Mckinlay, Bertram A Pitt, Marc A Pfeffer Mar 2016

Impact Of Spironolactone On Longitudinal Changes In Health-Related Quality Of Life In The Treatment Of Preserved Cardiac Function Heart Failure With An Aldosterone Antagonist Trial, Eldrin Lewis, Hae-Young Kim, Brian Claggett, John Spertus, John F Heitner, Susan F Assmann, Christopher T Kenwood, Scott D Solomon, Akshay S Desai, James C Fang, Sonia A Mckinlay, Bertram A Pitt, Marc A Pfeffer

NYMC Faculty Publications

BACKGROUND: Heart failure (HF) with preserved ejection fraction patients have equally impaired health-related quality of life (HRQL) compared with those with HF with reduced ejection fraction, but limited studies have evaluated the impact of therapies on changes in HRQL.

METHODS AND RESULTS: Patients ≥50 years of age, with symptomatic HF and left ventricular ejection fraction ≥45%, were enrolled in Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) and randomized to spironolactone or placebo. Patients completed the Kansas City Cardiomyopathy Questionnaire (KCCQ), which was the primary HRQL instrument, and EQ5D visual analog scale at baseline, 4 months, …


Why Is Postoperative Atrial Fibrillation Difficult To Prevent And Treat: Potential Roles Of Unrecognized Magnesium Deficiency And Release Of Ceramide And Platelet-Activating Factor, Burton M. Altura, Nilank C. Shah, Gatha J. Shah, Jose Luis Perez-Albela, Bella T. Altura Jan 2016

Why Is Postoperative Atrial Fibrillation Difficult To Prevent And Treat: Potential Roles Of Unrecognized Magnesium Deficiency And Release Of Ceramide And Platelet-Activating Factor, Burton M. Altura, Nilank C. Shah, Gatha J. Shah, Jose Luis Perez-Albela, Bella T. Altura

Touro College of Osteopathic Medicine (Middletown) Publications and Research

Heart failure is a major cause of morbidity and mortality whose costs impose staggering health-care costs and often lengthy hospitalizations. Post-operative atrial fibrillation (POAF) represents a leading cause for heart failure, particularly after cardiac and lung surgeries. Although PAOF is a common cardiac arrhythmia, it is impossible to predict. As the worldwide population is aging, the incidence and prevalence of PAOF is growing. Identifying mechanisms for PAOF is attracting a considerable amount of research with no agreement on the mechanism(s). Our research on the heart and cardiovascular system, over the past 50-plus years, leads us to believe that major causes …